Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone HCl in Acute Stroke
NCT05301712Phase 4Completed
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Aug 2018
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of naloxone in stroke, sponsored by Samjin Pharmaceutical Co., Ltd.. Started Aug 2018; status: completed.
02
Drugs
naloxone
03
Conditions
stroke
Beyond the preview
Go deeper on NCT05301712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05301712.